-
-
A BETA-3 ADRENERGIC AGONIST HAS BEEN APPROVED FOR the treatment of overactive bladder in adults. Mirabegron differs from other agents approved for this same indication, such as oxybutynin, tolterodine, solifenacin, darifenacin, etc., which are anticholinergic/antimuscarinic agents. Mirabegron is marketed by Astellas Pharma as Myrbetriq.
-
Clinical Briefs: Coffee Might be One Less Thing We Have to Worry About; ED, Lower Urinary Tract Symptoms, and Ejaculatory Dysfunction; The Allure of Shared Medical Appointments in Diabetes Care
-
In this study population with a 2% average risk of a major coronary event per year, LDL cholesterol, apolipoproteins, and LDL particle concentrations had similar and strong associations for major vascular events. The independent predictive value of HDL measures is less clear.
-
When routinely cultured, essentially all ICU privacy curtains were found to be contaminated with potential pathogens at least some of the time. Recovered organisms included methicillin-resistant staphylococci and vancomycin-resistant enterococci.
-
The benefits of regular physical activity are well known. Encouraging individuals to be active through recreational and competitive athletics while preventing and treating injuries is the role of the sports medicine physician.
-
The authors conclude that after weight loss, a low glycemic index and, to a lesser extent, low-protein diet may reduce inflammation associated with cardiovascular disease in overweight adults.
-
I have been a student of atrial fibrillation (AF) for some time, but had never come upon the term "subclinical" AF until this New England Journal of Medicine publication.
-
A small percentage of patients taking statins may develop muscle symptoms (pain and weakness) but elevated CK is rare.
-
Exposure to specific solvents, and trichloroethylene in particular, is associated with an increased risk of Parkinson's disease.
